The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Boron Chemistry for Medical Applications
Open accessAbstract
Boron compounds now have many applications in a number of fields, including Medicinal Chemistry. Although the uses of boron compounds in pharmacological science have been recognized several decades ago, surprisingly few are found in pharmaceutical drugs. The boron-containing compounds epitomize a new class for medicinal chemists to use in their drug designs. Carboranes are a class of organometallic compounds containing carbon (C), boron (B), and hydrogen (H) and are the most widely studied boron compounds in medicinal chemistry. Additionally, other boron-based compounds are of great interest, such as dodecaborate anions, metallacarboranes and metallaboranes. The boron neutron capture therapy (BNCT) has been utilized for cancer treatment from last decade, where chemotherapy and radiation have their own shortcomings. However, the improvement in the already existing (BPA and/or BSH) localized delivery agents or new tumor-targeted compounds are required before realizing the full clinical potential of BNCT. The work outlined in this short review addresses the advancements in boron containing compounds. Here, we have focused on the possible clinical implications of the new and improved boron-based biologically active compounds for BNCT that are reported to have in vivo and/or in vitro efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Animal Communication: When I’m Calling You, Will You Answer Too?
Vickers, N. J. (2017) · Current Biology · doi:10.1016/j.cub.2017.05.064 · Cited by 2,210
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
Park, J.-H., Gu, L., von Maltzahn, G., Ruoslahti, E., Bhatia, S. N., & Sailor, M. J. (2009) · Nature Materials · doi:10.1038/nmat2398 · Cited by 1,897
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
Barth, R. F., Coderre, J. A., Vicente, M. G. H., & Blue, T. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0035 · Cited by 1,046
Chen, Q., Feng, L., Liu, J., Zhu, W., Dong, Z., Wu, Y., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201601902 · Cited by 1,034
The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer
Hawthorne, M. F. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199309501 · Cited by 865
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Scholz, M., & Hey-Hawkins, E. (2011) · Chemical Reviews · doi:10.1021/cr200038x · Cited by 797
Metal–Organic Framework‐Based Stimuli‐Responsive Systems for Drug Delivery
Cai, W., Wang, J., Chu, C., Chen, W., Wu, C., & Liu, G. (2019) · Advanced Science · doi:10.1002/advs.201801526 · Cited by 744
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Núñez, R., Tarrés, M., Ferrer-Ugalde, A., de Biani, F. F., & Teixidor, F. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00198 · Cited by 576
Stimuli-Responsive Nanomaterials for Biomedical Applications
Blum, A. P., Kammeyer, J. K., Rush, A. M., Callmann, C. E., Hahn, M. E., & Gianneschi, N. C. (2015) · Journal of the American Chemical Society · doi:10.1021/ja510147n · Cited by 540
Barth, R. F., H Vicente, M., Harling, O. K., Kiger, W., Riley, K. J., Binns, P. J., Wagner, F. M., Suzuki, M., Aihara, T., Kato, I., et al. (2012) · Radiation Oncology · doi:10.1186/1748-717x-7-146 · Cited by 531
Applications of Radiolabeled Boron Clusters to the Diagnosis and Treatment of Cancer
Hawthorne, M. F., & Maderna, A. (1999) · Chemical Reviews · doi:10.1021/cr980442h · Cited by 527
Boron delivery agents for neutron capture therapy of cancer
Barth, R. F., Mi, P., & Yang, W. (2018) · Cancer Communications · doi:10.1186/s40880-018-0299-7 · Cited by 467
Ultrasound-mediated transdermal drug delivery: Mechanisms, scope, and emerging trends
Polat, B. E., Hart, D., Langer, R., & Blankschtein, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.006 · Cited by 447
Degradable natural polymer hydrogels for articular cartilage tissue engineering
Zhao, W., Jin, X., Cong, Y., Liu, Y., & Fu, J. (2013) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.3970 · Cited by 421
Challenges and Opportunities for the Application of Boron Clusters in Drug Design
Leśnikowski, Z. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01932 · Cited by 348
Icosahedral boron clusters: a perfect tool for the enhancement of polymer features
Núñez, R., Romero, I., Teixidor, F., & Viñas, C. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00159a · Cited by 346
The electronic structure of an icosahedron of boron atoms
Longuet-Higgins, H. C., & Roberts, M. D. V. (1955) · Proceedings of the Royal Society of London A Mathematical and Physical Sciences · doi:10.1098/rspa.1955.0115 · Cited by 320
π Aromaticity and Three‐Dimensional Aromaticity: Two sides of the Same Coin?
Poater, J., Solà, M., Viñas, C., & Teixidor, F. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407359 · Cited by 315
Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT)
Moss, R. L. (2014) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2013.11.109 · Cited by 294
Boron Chemicals in Diagnosis and Therapeutics
Das, B. C., Thapa, P., Karki, R., Schinke, C., Das, S., Kambhampati, S., Banerjee, S. K., Van Veldhuizen, P., Verma, A., Weiss, L. M., et al. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.38 · Cited by 279
Kankaanranta, L., Seppälä, T., Koivunoro, H., Saarilahti, K., Atula, T. S., Collan, J., Salli, E., Kortesniemi, M., Uusi-Simola, J., Välimäki, P., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.09.057 · Cited by 271
Biodegradable Hybrid Stomatocyte Nanomotors for Drug Delivery
Tu, Y., Peng, F., André, A. A. M., Men, Y., Srinivas, M., & Wilson, D. A. (2017) · ACS Nano · doi:10.1021/acsnano.6b08079 · Cited by 262
The Valence Structure of the Boron Hydrides
Eberhardt, W., Crawford, B. L., & Lipscomb, W. N. (1954) · The Journal of Chemical Physics · doi:10.1063/1.1740320 · Cited by 248
A realistic appraisal of boron neutron capture therapy as a cancer treatment modality
Barth, R. F., Zhang, Z., & Liu, T. (2018) · Cancer Communications · doi:10.1186/s40880-018-0280-5 · Cited by 248
Qian, E. A., Wixtrom, A. I., Axtell, J. C., Saebi, A., Jung, D., Rehak, P., Han, Y., Moully, E. H., Mosallaei, D., Chow, S., et al. (2017) · Nature Chemistry · doi:10.1038/nchem.2686 · Cited by 224
Poly(phosphoester)s: A new platform for degradable polymers
Steinbach, T., & Wurm, F. R. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500147 · Cited by 219
Justin, R., & Chen, B. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.12.012 · Cited by 215
In Vivo Clearance and Toxicity of Monodisperse Iron Oxide Nanocrystals
Gu, L., Fang, R. H., Sailor, M. J., & Park, J.-H. (2012) · ACS Nano · doi:10.1021/nn300456z · Cited by 209
Biodegradable Theranostic Plasmonic Vesicles of Amphiphilic Gold Nanorods
Song, J., Pu, L., Zhou, J., Duan, B., & Duan, H. (2013) · ACS Nano · doi:10.1021/nn403846v · Cited by 184
Synthesis and Applications of Perfunctionalized Boron Clusters
Axtell, J. C., Saleh, L. M. A., Qian, E. A., Wixtrom, A. I., & Spokoyny, A. M. (2018) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b02912 · Cited by 183
Ciofani, G., Raffa, V., Menciassi, A., & Cuschieri, A. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-008-9210-9 · Cited by 174
New ligand platforms featuring boron-rich clusters as organomimetic substituents
Spokoyny, A. M. (2013) · Pure and Applied Chemistry · doi:10.1351/pac-con-13-01-13 · Cited by 162
Treatment for small cell lung cancer, where are we now?-a review.
Alvarado-Luna, G., & Morales-Espinosa, D. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2016.01.13 · Cited by 156
New horizons for therapy based on the boron neutron capture reaction
Hawthorne, M. F. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01226-x · Cited by 140
Li, L., Li, J., Shi, Y., Du, P., Zhang, Z., Liu, T., Zhang, R., & Liu, Z. (2019) · ACS Nano · doi:10.1021/acsnano.9b04303 · Cited by 127
Tiwari, R., Mahasenan, K. V., Pavlovicz, R. E., Li, C., & Tjarks, W. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900031y · Cited by 122
Shikata, F., Tokumitsu, H., Ichikawa, H., & Fukumori, Y. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00198-9 · Cited by 122
Recent developments with boron as a platform for novel drug design
Lesnikowski, Z. J. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1174687 · Cited by 121
The use of immunotherapy in the treatment of melanoma
Achkar, T., & Tarhini, A. A. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0458-3 · Cited by 112
Wang, L.-W., Liu, Y.-W. H., Chou, F., & Jiang, S. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0295-y · Cited by 107
Identification of HSP60 as a Primary Target of o-Carboranylphenoxyacetanilide, an HIF-1α Inhibitor
Ban, H. S., Shimizu, K., Minegishi, H., & Nakamura, H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja104739t · Cited by 102
THE REACTIONS OF BIS-ACETONITRILE DECABORANE WITH AMINES
Hawthorne, M. F., & Pitochelli, A. R. (1959) · Journal of the American Chemical Society · doi:10.1021/ja01529a077 · Cited by 98
Li, J., Shi, Y., Zhang, Z., Liu, H., Lang, L., Liu, T., Chen, X. S., & Liu, Z. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00578 · Cited by 82
Soenen, S. J., Montenegro, J., Abdelmonem, A. M., Manshian, B. B., Doak, S. H., Parak, W. J., Smedt, S. C. D., & Braeckmans, K. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.09.041 · Cited by 70
Wu, C.-Y., Lin, J.-J., Chang, W.-Y., Hsieh, C.-Y., Wu, C.-C., Chen, H.-S., Hsu, H.-J., Yang, A., Hsu, M.-H., & Kuo, W.-Y. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110387 · Cited by 70
Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f
Sköld, K., Stenstam, B., Diaz, A. Z., Giusti, V., Pellettieri, L., & Hopewell, J. W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01267.x · Cited by 62
Hyaluronan as Carrier of Carboranes for Tumor Targeting in Boron Neutron Capture Therapy
Meo, C. D., Panza, L., Capitani, D., Mannina, L., Banzato, A., Rondina, M. B., Renier, D., Rosato, A., & Crescenzi, V. (2007) · Biomacromolecules · doi:10.1021/bm0607426 · Cited by 62
Lee, M. W., Sevryugina, Y. V., Khan, A. A., & Ye, S. Q. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300740t · Cited by 53
In Silico Carborane Docking to Proteins and Potential Drug Targets
Calvaresi, M., & Zerbetto, F. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200216z · Cited by 51
Applications and Perspectives of Boron-Enriched Nanocomposites in Cancer Therapy
Zhu, Y., & Hosmane, N. S. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.47 · Cited by 51
Self-citationBoron neutron capture therapy assisted by boron-conjugated nanoparticles
Sumitani, S., & Nagasaki, Y. (2012) · Polymer Journal · doi:10.1038/pj.2012.30 · Cited by 48
Nanostructured boron compounds for cancer therapy
Zhu, Y., & Hosmane, N. S. (2017) · Pure and Applied Chemistry · doi:10.1515/pac-2017-0903 · Cited by 48
Self-citationExploring Boron Neutron Capture Therapy for non-small cell lung cancer
Farías, R. O., Bortolussi, S., Menéndez, P. R., & González, S. J. (2014) · Physica Medica · doi:10.1016/j.ejmp.2014.07.342 · Cited by 47
Ionic Liquids: Recent Advances and Applications in Boron Chemistry
Zhu, Y., & Hosmane, N. S. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201700553 · Cited by 47
Self-citationSchaffran, T., Justus, E., Elfert, M., Chen, T., & Gabel, D. (2009) · Green Chemistry · doi:10.1039/b906165g · Cited by 43
Menichetti, L., Marchi, D. D., Calucci, L., Ciofani, G., Menciassi, A., & Forte, C. (2011) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2011.02.032 · Cited by 42
Takeuchi, I., Nomura, K., & Makino, K. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.08.002 · Cited by 41
Boron-enriched advanced energy materials
Zhu, Y., Gao, S., & Hosmane, N. S. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.11.037 · Cited by 39
Self-citationRemarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy
Chen, J., Yang, Q., Liu, M., Lin, M., Wang, T., Zhang, Z., Zhong, X., Guo, N., Lu, Y., Xu, J., et al. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s214224 · Cited by 39
The properties of substituted 3D-aromatic neutral carboranes: the potential for σ-hole bonding
Lo, R., Fanfrlík, J., Lepšı́k, M., & Hobza, P. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp03617h · Cited by 35
Nanostructured Biodegradable Polymer Networks Using Lyotropic Liquid Crystalline Templates
Clapper, J. D., Iverson, S. L., & Guymon, C. A. (2007) · Biomacromolecules · doi:10.1021/bm070167l · Cited by 31
The Current Status and Perspectives of Delivery Strategy for Boronbased Drugs
Zhu, Y., Lin, X., Xie, H., Li, J., Hosmane, N. S., & Zhang, Y. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180904105212 · Cited by 21
Self-citationWu, C. Y., Chan, P.-C., Chou, L.-S., Chang, C.-W., Yang, F., Liu, R. S., Chiou, S., Chen, Y., Yen, S. H., & Wang, H.-E. (2013) · Molecular Imaging and Biology · doi:10.1007/s11307-013-0675-2 · Cited by 13
Adamska‐Bartłomiejczyk, A., Bednarska, K., Białek‐Pietras, M., Kiliańska, Z. M., Mieczkowski, A., Olejniczak, A. B., Paradowska, E., Studzińska, M., Sułowska, Z., Żołnierczyk, J. D., et al. (2018) · Wiley eBooks · doi:10.1002/9781119275602.ch1.2 · Cited by 5
Development of Novel Tumor-Targeted Compounds for Boron Neutron Capture Therapy
Luderer, M. J. (2019) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/en1m-vp71 · Cited by 3
Metadata
- Authors
- Ali, F., S Hosmane, N., & Zhu, Y.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-02-13
- Volume
- 25
- Issue
- 4
- Pages
- 828
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W3006144386
- Cited by
- 270
- References
- 67
- FWCI
- 17.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.